disulfiram has been researched along with Hepatitis C in 7 studies
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although abstinence slows liver injury in alcoholic Hepatitis C (HCV) infected patients, few clinicians prescribe disulfiram because of concern over its hepatotoxic effect." | 9.11 | Disulfiram therapy in patients with hepatitis C: a 12-month, controlled, follow-up study. ( Alfers, J; Beresford, TP; Bialkowski, D; Bridgeford, D; Clapp, L; Kulig, C; Martin, B, 2004) |
| "A 43 year old man with HIV and HCV infection and liver cirrhosis developed fatal lactic acidosis within five days from starting nifedipine for arterial hypertension." | 7.75 | Fatal lactic acidosis precipitated by nifedipine in a patient treated with disulfiram and antiretrovirals. ( Mian, P; Moling, O; Pagani, L; Pristerà, R; Rimenti, G; Spoladore, G; Vedovelli, C, 2009) |
| "Disulfiram therapy may allow (1) prolonged abstinence leading to successful antiviral therapy for HCV, and (2) time to begin behavioral treatments that facilitate long-term abstinence." | 6.43 | Hepatitis C in alcohol dependence:drinking versus disulfiram. ( Beresford, TP; Kulig, CC, 2005) |
| "Although abstinence slows liver injury in alcoholic Hepatitis C (HCV) infected patients, few clinicians prescribe disulfiram because of concern over its hepatotoxic effect." | 5.11 | Disulfiram therapy in patients with hepatitis C: a 12-month, controlled, follow-up study. ( Alfers, J; Beresford, TP; Bialkowski, D; Bridgeford, D; Clapp, L; Kulig, C; Martin, B, 2004) |
| "A 43 year old man with HIV and HCV infection and liver cirrhosis developed fatal lactic acidosis within five days from starting nifedipine for arterial hypertension." | 3.75 | Fatal lactic acidosis precipitated by nifedipine in a patient treated with disulfiram and antiretrovirals. ( Mian, P; Moling, O; Pagani, L; Pristerà, R; Rimenti, G; Spoladore, G; Vedovelli, C, 2009) |
| " Two of these had been treated with disulfiram and a drug aetiology could not be excluded, but in six patients no known cause of fulminant hepatitis could be determined and these patients were classified as having hepatitis type non-A non-B." | 3.66 | Hepatitis type A, B, and non-A non-B in fulminant hepatitis. ( Mathiesen, LR; Nielsen, JO; Purcell, RH; Ranek, L; Skinoj, P; Wong, D, 1980) |
| "Disulfiram therapy may allow (1) prolonged abstinence leading to successful antiviral therapy for HCV, and (2) time to begin behavioral treatments that facilitate long-term abstinence." | 2.43 | Hepatitis C in alcohol dependence:drinking versus disulfiram. ( Beresford, TP; Kulig, CC, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thibault, A | 1 |
| Brissette, S | 1 |
| Jutras-Aswad, D | 1 |
| Moling, O | 1 |
| Rimenti, G | 1 |
| Pristerà, R | 1 |
| Vedovelli, C | 1 |
| Pagani, L | 1 |
| Spoladore, G | 1 |
| Mian, P | 1 |
| Martin, B | 2 |
| Alfers, J | 1 |
| Kulig, C | 1 |
| Clapp, L | 1 |
| Bialkowski, D | 1 |
| Bridgeford, D | 1 |
| Beresford, TP | 3 |
| Kulig, CC | 1 |
| Mathiesen, LR | 1 |
| Skinoj, P | 1 |
| Nielsen, JO | 1 |
| Purcell, RH | 1 |
| Wong, D | 1 |
| Ranek, L | 1 |
| Saxon, AJ | 1 |
| Sloan, KL | 1 |
| Reoux, J | 1 |
| Haver, VM | 1 |
2 reviews available for disulfiram and Hepatitis C
| Article | Year |
|---|---|
Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C.
Topics: Alcohol Deterrents; Alcohol-Related Disorders; Baclofen; Disulfiram; Hepatitis C; Humans; Transamina | 2015 |
Hepatitis C in alcohol dependence:drinking versus disulfiram.
Topics: Alcohol Deterrents; Alcoholism; Disulfiram; Hepatitis C; Humans; Liver | 2005 |
1 trial available for disulfiram and Hepatitis C
| Article | Year |
|---|---|
Disulfiram therapy in patients with hepatitis C: a 12-month, controlled, follow-up study.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Chi-Square Distribution; Disulfiram; Femal | 2004 |
4 other studies available for disulfiram and Hepatitis C
| Article | Year |
|---|---|
Fatal lactic acidosis precipitated by nifedipine in a patient treated with disulfiram and antiretrovirals.
Topics: Acidosis, Lactic; Adult; Alcohol Deterrents; Alcoholism; Anti-Retroviral Agents; Antihypertensive Ag | 2009 |
Disulfiram in context: structure and safety.
Topics: Alcohol Deterrents; Alcoholism; Disulfiram; Hepatitis C; Humans; Liver Function Tests; Patient Compl | 2007 |
Hepatitis type A, B, and non-A non-B in fulminant hepatitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Disulfiram; Female; | 1980 |
Disulfiram use in patients with abnormal liver function test results.
Topics: Adult; Alanine Transaminase; Alcohol Deterrents; Alcoholism; Aspartate Aminotransferases; Comorbidit | 1998 |